Rift Valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Filone, Claire Marie ^a,b   Hanna, Sheri L ^a   Cecilia Caino, M ^a   Bambina, Shelly ^a   Doms, Robert W ^a   Cherry, Sara ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; AMMONIUM CHLORIDE; BREFELDIN A; CALPHOSTIN C; CHELERYTHRINE; CHLOROQUINE; CYTOCHALASIN D; ISOENZYME; METHOTREXATE; MIBEFRADIL; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; RIBAVIRIN; RO 3320432; ROTTLERIN; SANGUINARINE; SPIPERONE; THAPSIGARGIN; THIORIDAZINE; UNCLASSIFIED DRUG; VINBLASTINE SULFATE; WORTMANNIN; ACETOPHENONE DERIVATIVE; BENZOPHENANTHRIDINE DERIVATIVE; BENZOPYRAN DERIVATIVE; ENZYME INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; ENZYME ACTIVITY; ENZYME INHIBITION; FLY; HIGH THROUGHPUT SCREENING; HOST CELL; HUMAN; HUMAN CELL; IC 50; INSECT CELL; NONHUMAN; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; TISSUE CULTURE; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CELL LINE; CELL STRAIN HEK293; CERCOPITHECUS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOBLOTTING; INSECT; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; VERO CELL; VIROLOGY;

ARTHROPODA; HEXAPODA; MAMMALIA; RIFT VALLEY FEVER VIRUS;

ACETOPHENONES; ANIMALS; BENZOPHENANTHRIDINES; BENZOPYRANS; CELL LINE; CERCOPITHECUS AETHIOPS; DIPTERA; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; INSECTS; PROTEIN KINASE C-EPSILON; RIFT VALLEY FEVER VIRUS; RNA INTERFERENCE; VERO CELLS;

EID: 78649660536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015483     Document Type: Article

References (44)

1. Gubler DJ (2002) The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33: 330-342.
2. Schmaljohn CS, Hooper JW (2001) Bunyaviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippencott, Williams and Wilkens.
3. Flick R, Bouloy M (2005) Rift Valley fever virus. Curr Mol Med 5: 827-834.
4. Gad AM, Hassan MM, el Said S, Moussa MI, Wood OL (1987) Rift Valley fever virus transmission by different Egyptian mosquito species. Trans R Soc Trop Med Hyg 81: 694-698.
5. Jupp PG, Cornel AJ (1988) Vector competence tests with Rift Valley fever virus and five South African species of mosquito. J Am Mosq Control Assoc 4: 4-8.
6. Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, et al. (2000) The genome sequence of Drosophila melanogaster. Science 287: 2185-2195.
7. Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401-415.
8. Echeverri CJ, Perrimon N (2006) High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet 7: 373-384.
9. Perrimon N (1998) New advances in Drosophila provide opportunities to study gene functions. Proc Natl Acad Sci U S A 95: 9716-9717.
10. Pinheiro VB, Ellar DJ (2006) How to kill a mocking bug? Cell Microbiol 8: 545-557.
11. Royet J, Reichhart JM, Hoffmann JA (2005) Sensing and signaling during infection in Drosophila. Curr Opin Immunol 17: 11-17.
12. Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, et al. (2000) Comparative genomics of the eukaryotes. Science 287: 2204-2215.
13. White KP, Rifkin SA, Hurban P, Hogness DS (1999) Microarray analysis of Drosophila development during metamorphosis. Science 286: 2179-2184.
14. Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, et al. (2007) A genomewide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448: 151-156.
15. Cherry S, Doukas T, Armknecht S, Whelan S, Wang H, et al. (2005) Genomewide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev 19: 445-452.
16. Marsh M, Helenius A (2006) Virus entry: open sesame. Cell 124: 729-740.
17. Amstutz B, Gastaldelli M, Kalin S, Imelli N, Boucke K, et al. (2008) Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J 27: 956-969.
18. Coyne CB, Shen L, Turner JR, Bergelson JM (2007) Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2: 181-192.
19. Mercer J, Helenius A (2008) Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320: 531-535.
20. Caplen H, Peters CJ, Bishop DH (1985) Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 66 (Pt 10): 2271-2277.
21. Vialat P, Muller R, Vu TH, Prehaud C, Bouloy M (1997) Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. Virus Res 52: 43-50.
22. Wasmoen TL, Kakach LT, Collett MS (1988) Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins. Virology 166: 275-280.
23. Gerrard SR, Nichol ST (2002) Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J Virol 76: 12200-12210.
24. Zhang XD, Yang XC, Chung N, Gates A, Stec E, et al. (2006) Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. Pharmacogenomics 7: 299-309.
25. Swanson JA (2008) Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol 9: 639-649.
26. Newton AC (2001) Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101: 2353-2364.
27. Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB, et al. (2003) Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol Cell 11: 1101-1108.
28. Fiering S, Northrop JP, Nolan GP, Mattila PS, Crabtree GR, et al. (1990) Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev 4: 1823-1834.
29. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, et al. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197.
30. Broughton SJ, Kane NS, Arthur B, Yoder M, Greenspan RJ, et al. (1996) Endogenously inhibited protein kinase C in transgenic Drosophila embryonic neuroblasts down regulates the outgrowth of type I and II processes of cultured mature neurons. J Cell Biochem 60: 584-599.
31. Schaeffer E, Smith D, Mardon G, Quinn W, Zuker C (1989) Isolation and characterization of two new drosophila protein kinase C genes, including one specifically expressed in photoreceptor cells. Cell 57: 403-412.
32. Mitzner D, Dudek SE, Studtrucker N, Anhlan D, Mazur I, et al. (2009) Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol 11: 1502-1516.
33. Volmer R, Monnet C, Gonzalez-Dunia D (2006) Borna disease virus blocks potentiation of presynaptic activity through inhibition of protein kinase C signaling. PLoS Pathog 2: e19.
34. Ennaciri J, Ahmad R, Menezes J (2007) Interaction of monocytic cells with respiratory syncytial virus results in activation of NF-kappaB and PKC-alpha/ beta leading to up-regulation of IL-15 gene expression. J Leukoc Biol 81: 625-631.
35. Chu JJ, Leong PW, Ng ML (2006) Analysis of the endocytic pathway mediating the infectious entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells. Virology 349: 463-475.
36. Ramanathan HN, Jonsson CB (2008) New and Old World hantaviruses differentially utilize host cytoskeletal components during their life cycles. Virology 374: 138-150.
37. Prekeris R, Hernandez RM, Mayhew MW, White MK, Terrian DM (1998) Molecular analysis of the interactions between protein kinase C-epsilon and filamentous actin. J Biol Chem 273: 26790-26798.
38. Ellis DS, Shirodaria PV, Fleming E, Simpson DI (1988) Morphology and development of Rift Valley fever virus in Vero cell cultures. J Med Virol 24: 161-174.
39. Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, et al. (2002) Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 158: 1119-1131.
40. Schmitz-Peiffer C, Laybutt DR, Burchfield JG, Gurisik E, Narasimhan S, et al. (2007) Inhibition of PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin clearance. Cell Metab 6: 320-328.
41. Garcia S, Crance JM, Billecocq A, Peinnequin A, Jouan A, et al. (2001) Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J Clin Microbiol 39: 4456-4461.
42. Peters CJ, Reynolds JA, Slone TW, Jones DE, Stephen EL (1986) Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res 6: 285-297.
43. Coyne CB, Kim KS, Bergelson JM (2007) Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2. EMBO J 26: 4016-4028.
44. Cherry S, Perrimon N (2004) Entry is a rate-limiting step for viral infection in a Drosophila melanogaster model of pathogenesis. Nat Immunol 5: 81-87.